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BES1 Accumulates in the Nucleus in Response
to Brassinosteroids to Regulate Gene Expression
and Promote Stem Elongation
(BL), the most active BR (Mussig and Altmann, 1999),
genetic studies have been less illuminating in identifying
components of the BR signaling pathway.
Extensive loss-of-function genetic screens for BR-
insensitive dwarf mutants have identified mutations
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mann et al., 1996; Li and Chory, 1997). Unlike animalLa Jolla, California 92037
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gene expression upon ligand binding (Beato and Klug,Developmental Biology
2000; Mangelsdorf et al., 1995), BR signals are perceivedUniversity of Michigan
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cellular domain containing 25 LRRs interrupted by aWako-shi, Saitama 351-0198
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domain, and an intracellular serine/threonine kinase do-
main (Li and Chory, 1997). A chimeric receptor com-
posed of the BRI1 extracellular domain and the kinaseSummary
domain of Xa21, a rice LRR receptor kinase for disease
resistance, confers BL-dependent pathogen responsesPlant steroid hormones, known as brassinosteroids
to rice cells (He et al., 2000). In addition, both membrane(BRs), signal through a plasma membrane localized
fractions and immunoprecipitates containing BRI1 bindreceptor kinase BRI1. We identified bes1, a semidomi-
3H-labeled BL specifically, and such binding is greatlynant suppressor of bri1, which exhibits constitutive
reduced in plants harboring mutations in the extracellu-BR response phenotypes including long and bending
lar domain (Wang et al., 2001). BRI1’s kinase domainpetioles, curly leaves, accelerated senescence, and
displays serine/threonine kinase activity in vitro, and BLconstitutive expression of BR-response genes. BES1
treatment in plants induces BRI1 autophosphorylationaccumulates in the nucleus in response to BRs. BES1
(Friedrichsen et al., 2000; Oh et al., 2000; Wang et al.,is phosphorylated and appears to be destabilized by
2001). Thus, all available evidence strongly implicatesthe glycogen synthase kinase-3 (GSK-3) BIN2, a nega-
BRI1 as a critical component of the BR-receptor com-tive regulator of the BR pathway. These results estab-
plex, which likely transduces the BR signal to down-lish a signaling cascade for BRs with similarities to the
stream targets through its kinase domain.Wnt pathway, in which signaling through cell surface
BL is known to induce the expression of several genesreceptors leads to inactivation of a GSK-3 allowing
(Clouse, 1996; Friedrichsen and Chory, 2001); however,accumulation of a nuclear protein that regulates target
nothing is known about the mechanism by which the
gene expression.
BL signal is transduced from BRI1 to BL-target genes
in the nucleus. Despite significant efforts in several labo-
Introduction ratories, no other BR-insensitive loss-of-function mu-
tants have been identified with the same phenotypes as
Brassinosteroids (BRs) are plant hormones affecting a bri1. This suggests that other BR signaling components
variety of processes, such as stem elongation, leaf de- may be encoded either by redundant genes so that their
velopment, pollen tube growth, xylem differentiation, loss-of-function mutations may not have bri1-like phe-
senescence, and photomorphogenesis (Clouse, 1996; notypes or by essential genes so that loss-of-function
Mandava, 1988). Molecular characterization of Arabi- mutations would be lethal.
dopsis BR biosynthetic mutants has provided genetic There is evidence for both of these possibilities. A
evidence for the essential roles of BRs in normal plant BR-insensitive semidominant mutant, bin2, displays
growth and development (Li and Chory, 1999). These bri1-like dwarf phenotypes; the semidominance of the
BR-deficient mutants display pleiotropic dwarf pheno- mutation and gene dosage studies suggest that BIN2
types, including short hypocotyls and leaf petioles, epi- is a negative regulator of the BR pathway (Li et al., 2001).
nastic and dark green leaves, reduced apical dominance ucu1 mutants, allelic to bin2, have also been identified
and male fertility, delayed senescence and flowering, as leaf development mutants (Pe´rez-Pe´rez et al., 2002).
as well as de-etiolation in the dark (Li and Chory, 1999). BIN2/UCU1 encodes a serine/threonine kinase with sig-
While the characterization of BR-deficient mutants has nificant homology to GSK-3/SHAGGY kinases (Li and
established the biosynthetic pathway for brassinolide Nam, 2002; Pe´rez-Pe´rez et al., 2002), of which there are
at least ten family members in Arabidopsis (Dornelas et
al., 1998). Molecular genetic studies support that BIN24 Correspondence: chory@salk.edu
is a negative regulator of the BR signaling pathway (Li5 Present address: Department of Plant Biology, Carnegie Institution
of Washington, Stanford, California 94305. and Nam, 2002). First, dominant mutations in BIN2 in-
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Figure 1. bes1-D Suppresses bri1 Phenotypes and Is Resistant to the BR-Biosynthesis Inhibitor Brassinazole (BRZ)
(A) Three-week-old light-grown seedlings in 1⁄2 MS medium.
(B) Two-month-old plants grown in soil.
(C) Five-day-old dark-grown seedlings.
(D) Two-week-old light-grown seedlings in 1⁄2 MS medium without (upper panel) or with 1 M BRZ (lower panel).
(E) The hypocotyl length of 7-day-old dark-grown seedlings in the absence or presence of 1 M BRZ. At least 10 hypocotyls were measured
for each treatment. The error bars indicate standard deviation. WT is En2.
crease its kinase activity as judged by both autophos- a mutant, bes1 (bri1-EMS-suppressor 1), which not only
suppresses bri1 dwarf phenotypes but also displaysphorylation and transphosphorylation activities. Over-
expression of the wild-type BIN2 gene results in a constitutive BR response phenotypes. We cloned the
BES1 gene and found that it encodes a phosphoproteinportion of transgenic plants with similar phenotypes to
bin2 mutants, suggesting that the bin2 mutations are with high identity to BZR1 (Wang et al., 2002). BES1
accumulates in the nucleus in response to BL treatment,hypermorphic. Moreover, while overexpression of BIN2
in a weak bri1 allele enhances bri1 phenotypes, reduc- but not to treatments by other hormones. We provide
genetic and biochemical evidence that BES1 is a sub-tion of BIN2 levels in bri1 plants suppresses bri1 pheno-
types. These results suggest that BIN2 acts downstream strate for and is negatively regulated by BIN2. In addi-
tion, we show that downstream target genes are consti-from BRI1 to negatively regulate the BR signaling path-
way (Li and Nam, 2002). However, at this juncture, there tutively expressed or hyperinduced in the bes1 mutant.
The results establish a signaling cascade that begins tois no evidence that BIN2 is regulated by BRI1, nor has
BIN2 been connected to other signaling components in connect the BL signal to gene expression changes in
the nucleus that alter plant growth and development.the pathway.
A role for essential genes in the BR signaling pathway
comes from studies of the Arabidopsis det3 mutant. Results
det3 is a dwarf mutant with a de-etiolated phenotype
that is also insensitive to BL applications (Cabrera y bes1-D Displays Constitutive BR Responses
To identify signaling components downstream of BRI1,Poch et al., 1993; Szekeres et al., 1996). DET3 encodes
the large C subunit (an assembly subunit) of the vacuolar we screened for suppressors of bri1-119, a weak allele
of bri1 that harbors a missense mutation in the 70 aminoproton-ATPase (V-ATPase; Schumacher et al., 1999). In
the dark, the hypocotyl elongation defect of det3, a very acid island domain (G644D; Friedrichsen et al., 2000).
bri1-119 plants, like other bri1 mutants, are dark greenweak allele, is somewhat specific for BRs because the
mutant hypocotyls can elongate in response to gravity dwarves with short petioles and round and epinastic
leaves (Figure 1A). We mutagenized 40,000 homozygouswhen grown upside down. Thus, it seems likely that BR
action utilizes V-ATPase activity to initiate changes in bri1-119 seeds with ethyl methanesulfonate (EMS). Ap-
proximately 200,000 M2 seedlings were screened inthe cellular environment, such as the uptake of water
into the vacuole, to promote BR-induced cell elongation. white light for mutant plants with suppressed bri1 phe-
notypes. One suppressor named bes1 (bri1-EMS-sup-However, the V-ATPase appears to act in several signal-
ing pathways, only one of which is the cell elongation pressor 1) was identified in a single pool and showed
complete suppression of the bri1 phenotypes (Figureresponse induced by BRs.
Here, we report the isolation and characterization of 1A). When backcrossed to bri1-119, the resulting plants,
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Table 1. BR-Induced Genes Are Upregulated or Hyperresponsive to BL in bes1-D Mutants
Col bes1-D
Gene No. Et BL Et BL Gene
Group 1 At2g26710 1068 3640.2 2244 8839 Bas1D cytochrome P450 CYP72B
At4g38850 1026 3438 2585 8670 SAUR-AC1 small auxin up mRNA
At4g38860 2164 4398 4408 8719 Auxin-induced protein, similar to SAUR-AC1
At2g21200 357 1282 807 1719 Auxin-induced protein, similar to SAUR-AC1
At3g15540 897 2700 1315 3434 IAA19 early auxin-induced protein
At2g14900 6320 13873 9909 19988 GASA3 gibberellin-regulated protein
At4g19120 1269 2647 1908 5383 ERD3 early response to dehydration gene
At2g31730 1629 3517 3541 5990 Similar to ethylene regulated protein LeER33
At5g57560 6859 41562 21466 50564 TCH4 Xyloglucan endotransglycosylase
At4g25810 325 1435 1392 9043 XTR6 Xyloglucan endotransglycosylase
At1g23760 271 587 424 815 Putative polygalacturonase beta subunit
At4g02330 433 1234 1184 2861 Putative pectin methylesterase
At4g08950 5238 19757 11131 35040 AtPhi-1 phosphate-induced protein
At1g69490 249 1092 1866 4082 No Apical Meristem-like protein
At2g47060 1260 3260 2120 4901 Putative protein kinase
At1g21820 1678 4086 3023 7189 unknown protein
At1g21830 1901 3332 3395 7204 unknown protein
At2g32560 2594 4572 3915 6208 unknown protein
At2g36220 741 3252 2072 8658 unknown protein
Group 2 At1g04610 917 2497 809 3255 Flavin monooxygenase
At4g36110 307 1136 433 5758 Auxin-induced protein, similar to SAUR-AC1
At5g13870 1292 2844 1644 3650 EXGT-A4 Xyloglucan endotransglycosylase
At1g65310 1006 2591 1230 4950 Putative xyloglucan endoglucanase
At2g40610 4248 6924 4955 10152 Putative expansin
At2g35710 1301 2403 1601 4535 Putative glycogenin
At1g30690 2127 3859 1863 6766 Phosphatidylinositol/phosphatidylcholine transfer protein
At4g20780 2840 4884 3147 6799 Putative Ca-dependent protein kinase
At4g24230 1657 5377 1845 7427 unknown protein
At4g01950 1218 3490 1373 5385 unknown protein
At4g09890 1603 3467 1655 7409 unknown protein
Seedlings were treated with BL or mock treatment (Et, ethanol) and used to prepare RNA for microarray analysis using Affymetrix Arabidopsis
Gene Chip. The raw data are presented to indicate gene expression levels.
heterozygous for the bes1 mutation, showed similar but seedlings overexpressing BRI1 (Wang et al., 2002, 2001;
Figure 1D). In the dark, 1 M BRZ inhibited elongationsomewhat weaker bes1 phenotypes (Figure 1A). F2
plants segregated bes1-like and bri1 plants in a 3:1 ratio of hypocotyls of wild-type (55% inhibition), while bri1-
119 was hypersensitive to the inhibitor (75% inhibition;(data not shown), demonstrating that bes1 was caused
by a monogenic semidominant mutation, and therefore Figure 1E). bes1-D bri1-119 double mutants displayed
insensitivity to BRZ (hypocotyl lengths with and withoutnamed bes1-D.
bes1-D bri1-119 double mutants had long and bend- BRZ were not significantly different). Together, these
results demonstrate that bes1-D is a BR-pathway con-ing leaf petioles, curly leaves, and displayed early senes-
cence (Figures 1A and 1B). These phenotypes are similar stitutively active mutant whose phenotypes are inde-
pendent of both BRs and their receptor, BRI1.to plants overproducing BRs or BRI1 (Choe et al., 2001;
Wang et al., 2001), suggesting that bes1-D not only fully
suppresses the bri1 mutation, but also leads to a BL BR-Regulated Genes Are Either Upregulated
or Hyperresponsive to BL Treatmenthypersensitive phenotype. In the wild-type BRI1 back-
ground, bes1-D plants had almost the same phenotype in bes1-D
To further reveal the molecular mechanisms underlyingas those of bes1-Dbri1-119 (Figure 1B), demonstrating
that a functional BRI1 is not required for the bes1-D the bes1-D constitutive BR response phenotypes, we
performed expression-profiling experiments using thephenotype. In the dark, bes1-D also completely sup-
pressed the bri1-119 deetiolation phenotype, having elon- commercially available Arabidopsis Affymetrix Gene Chip
(Table 1). Seedlings of wild-type, bes1-D, and bri1-116gated hypocotyls and closed cotyledons (Figure 1C).
A BR biosynthesis inhibitor, brassinazole (BRZ), was (Q583Z) were either mock treated or treated with 1 M
BL for 2.5 hr. Among 8300 genes present on each array,used to test if bes1-D phenotypes require BRs. BRZ
specifically blocks BR biosynthesis at the C-22 hydroxy- at least 5500 genes gave signals that were above the
background in bes1-D, bri1-116, and the wild-type.lation step, reducing endogenous BR levels, and caus-
ing wild-type plants to resemble BR-deficient dwarfs About 120 genes that were upregulated in both wild-type
and bes1-D by BL treatments were chosen for cluster(Asami et al., 2000). bes1-D bri1-119 was insensitive to
the effects of BRZ in both the light and the dark (Figures analysis using the GeneSpring program. One cluster of
30 genes was induced by BL in both wild-type and1D and 1E). The light phenotype of bes1-D is in contrast
to other BRZ-resistant genotypes, such as bzr1-D and bes1-D but was not significantly changed after BL treat-
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ment in bri1 (Table 1, and data not shown). These 30
BL-induced genes were subdivided into two categories
according to their expression levels in bes1-D. Group 1
contained 19 BL-induced genes, whose basal expres-
sion levels (mock treatment) were upregulated by about
2-fold in bes1-D compared to wild-type and whose in-
duction by BL was largely unaffected. In Group 2, there
were 11 BL-induced genes whose basal expression lev-
els in bes1-D were comparable to those of the control
but whose induction by BL was about 2-fold greater
than wild-type, suggesting that this second group of
genes was hyperresponsive to BL treatment in the
mutant. Of the 30 BR-induced genes, 7 encode puta-
tive cell wall-associated proteins, including xyglucan
endotransglycosylases (XETs), endo-1,4--glucanases
(EGases), polygalacturonase, pectin methylesterase, or
expansin (Table 1), all of which are implicated in cell
elongation or expansion (Darley et al., 2001; Friedrichsen
and Chory, 2001; Lamport, 2001; Nicol et al., 1998). Sur-
prisingly, 5 of the BL-induced genes are either known
to be early auxin induced or share homology to auxin-
induced genes. The increased expression of BL-induced
genes in bes1-D or their hyperinduction by BL in the
mutants provides molecular evidence for the bes1-D
constitutive BL-response phenotypes and suggests that
the bes1-D phenotypes result from changes in gene
expression.
BES1 Encodes a BZR1-like Protein
and Is Ubiquitously Expressed
The similar BRZ-resistant phenotypes of bes1-D and
bzr1-D seedlings grown in the dark suggested that BES1 Figure 2. Structure of BES1 Protein, Recapitulation of bes1-D Phe-
may encode a BZR1-like protein (Wang et al., 2002). We notypes, and BES1 Expression Pattern
sequenced BZR2, a gene whose predicted products (A) BES1 gene, At1g19350, contains two exons and one intron and
share 88% identity with BZR1 from bes1-D and found encodes a polypeptide of 335 amino acids. The putative nuclear
a single change (C to T) at nucleotide position 698 rela- localization signal, the mutation in bes1-D, and a putative PEST
sequence are underlined.tive to the translational start site. This mutation causes
(B and C) Transgenic expression of mutant bes1 gene under thea change from a proline to a leucine residue at position
control of the CaMV 35S promoter (B) or the BES1 promoter (C)233. The same mutation was identified in the BZR1 gene
recapitulates bes1-D mutant phenotypes.
of the bzr1 mutant, strongly suggesting that BES1 is (D–G) BES1 is ubiquitously expressed as revealed by GUS reporter
BZR2. The gene is named BES1 hereafter. In addition expression. Reporter gene expression was observed in light-grown
to BZR1, BES1 also shares significant homology to four seedlings of 4-day-old (D) and 15-day-old (E) with a microscope
view of leaf (F), as well as 7-day-old dark-grown-hypocotyls (G).other Arabidopsis proteins (Wang et al., 2002). The pre-
dicted BES1 protein contains 335 amino acid residues
and has no significant homology to any known protein
outside of the BZR1 gene family, with the exception of and curly leaves, recapitulating the bes1-D mutant phe-
notypes (Figures 2B and 2C). Plants that overexpresseda putative bipartite nuclear localization signal (NLS) in
the N terminus of the protein (Figure 2A). The central mutant bes1 protein displayed even stronger pheno-
types than bes1-D (Figure 2B lower plant, and data notpart of BES1 is rich in serine residues and contains
22 consensus sites (S/TXXXS/T) for phosphorylation by shown). These results confirm that the mutation in the
BES1 gene was the cause of the mutant phenotypes.GSK-3 kinases (Wang et al., 2002). In addition, a putative
PEST sequence was identified from amino acids 231– We want to point out that a few 35S::BES1 transgenic
lines expressing higher BES1 displayed subtle but no-250, a region that encompasses the bes1 mutation
(Rechsteiner and Rogers, 1996). ticeable bes1-D phenotypes (data not shown), indicating
that increased BES1 protein may, at least partially,To confirm that the mutation in BES1 caused the mu-
tant phenotypes, both wild-type and mutant BES1 genes cause the mutant phenotype. However, the inability to
obtain 35S::BES1 plants with strong bes1-D phenotypeswere cloned into binary vectors under the control of
either the strong constitutive cauliflower mosaic virus suggests that other factors are involved in BES1
function.35S promoter or the BES1 promoter, and transformed
into Arabidopsis plants. While expression of wild-type To determine the expression pattern of BES1, a BES1
genomic fragment containing a 2 kb promoter, the in-BES1 did not cause any visible phenotypes in most of
the transgenic lines, expression of the mutant bes1-D tron, and two exons was fused in frame with the
-glucuronidase (GUS) reporter gene and the resultinggene resulted in long and bending petioles and narrow
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Figure 3. BES1 Accumulation in the Nucleus in Response to BL Treatment
(A) Wild-type BES1::GFP is present in the nucleus at relatively low levels in dark-grown hypocotyl cells without BL treatment (upper-left). BL
treatment for 24 hr increased the BES1-GFP nuclear accumulation (upper-right). Lower panels show nuclei stained with DAPI.
(B) Mutant bes1::GFP accumulates in the nucleus at high levels independent of BL.
(C) A time course study shows that 1 M BL induces BES1-GFP nuclear accumulation in 30 min and such accumulation continues to increase
until 90 min.
(D) IAA does not induce BES1::GFP nuclear accumulation.
construct was used to make transgenic plants. Histo- der the control of the CaMV 35S promoter and intro-
chemical analysis of GUS expression in T2 transgenic duced into wild-type Arabidopsis. The overexpressed
plants indicated that BES1 is ubiquitously expressed in mutant bes1::GFP resulted in strong bes1-D-like pheno-
cotyledons, leaves, hypocotyls, and roots of light-grown types, indicating that the fusion protein was functional.
plants (Figures 2D–2F), as well as in dark-grown hypo- In dark-grown seedlings, BES1::GFP was found in both
cotyls (Figure 2G). Stronger expression was observed the nucleus and cytoplasm at low levels in a fraction of
in leaf petioles, hypocotyls, and vascular tissues, which cells in most regions of the hypocotyl (Figure 3A, left
is similar to that of BRI1 expression and is consistent panel), although stronger nuclear localization was ob-
with the pronounced effects of the bes1-D mutation on served in the top part of hypocotyls in which cell elonga-
stem elongation. tion takes place (data not shown). In the cells with lower
BES1 levels, treatment with 1 M BL for 24 hr resulted
in a significant increase of BES1 in the nucleus (FigureBES1 Accumulates in the Nucleus
3A, right panel), suggesting that BL induces BES1 nu-in Response to BL
clear accumulation. To confirm this observation, we fol-The bes1-D mutant phenotypes and its gain-of-function
lowed single cells after addition of BL and found thatnature suggest that BES1 acts downstream of BRI1 as
BL treatment triggered nuclear accumulation of BES1a positive component in the BR signaling pathway. To
protein as early as 30 min and such accumulation in-reveal the subcellular localization of BES1 protein, a
creased for at least 90 min (Figure 3C). This rapid BES1green fluorescent protein (GFP) fusion to the C terminus
of full-length BES1 or mutant bes1, was expressed un- nuclear accumulation appeared to be BL specific since
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strongly suggesting that the fast band is unphosphory-
lated and the slow band is phosphorylated BES1::GFP.
Interestingly, BL treatment resulted in accumulation of
unphosphorylated BES1::GFP (about 5-fold; Figure 4A,
lanes 1 and 2), suggesting that BES1 is regulated by a
negatively acting kinase. In contrast, mutant bes1::GFP
protein accumulated at much higher levels (10-fold,
compared to wild-type BES1) even without BL treat-
ment,although BL still induced accumulation of the un-
phosphorylated form (Figure 4A, lanes 3 and 4, and
Figure 4D). Northern blot analysis indicated that the
transgenic lines used had comparable mRNA expres-
sion levels for BES1::GFP and bes1-D::GFP (data not
shown), suggesting that the mutation in bes1-D likely
stabilizes the protein in mutant plants.
A time course study indicated that BL treatment in-
creased the accumulation of unphosphorylated protein
as early as 30 min, and such accumulation continued
to increase until 8 hr and started to decrease after 24
hr (Figure 4C). Treatment of BES1::GFP transgenic
plants with other plant hormones such as auxin (IAA),
abscisic acid (ABA), cytokinin (BAP), and gibberellins
(GA3) did not produce such effects, suggesting that the
Figure 4. BL Induces Accumulation of Unphosphorylated BES1 in Vivo accumulation of unphosphorylated BES1 protein is BL
(A) Western blot shows that BL induces accumulation of a fast- specific (Figure 4C). Similar results were observed with
migrating form of wild-type BES1::GFP in transgenic plants and bes1-D::GFP transgenic plants (Figure 4D).
that mutant bes1::GFP accumulates at high levels in plants in the To determine if the BL-induced accumulation of unphos-
absence of BL.
phorylated BES1 is dependent on BRI1, a 35S::BES1-(B) Treatment of BES::GFP from transgenic plants with calf alkaline
GFP transgenic line was crossed to bri1-101 (E1078K)phosphatase (CIP) eliminated the slow band, suggesting that the
slow band is phosphorylated and the fast band is unphosphorylated and F2 plants with bri1 dwarf phenotypes and harboring
BES1. the transgene were used in a Western blot analysis. As
(C) A Western blot shows the kinetics of BL-induced accumulation shown in Figure 4E, the accumulation of unphosphory-
of unphosphorylated BES1. Other plant hormones such as IAA, BAP, lated BES1 is greatly reduced in the bri1 background.
GA3, and ABA do not stimulate accumulation of unphosphorylated
This result provides direct evidence that BES1 actsBES1.
downstream of BRI1.(D) BL induces the accumulation of unphosphorylated bes1::GFP
within 1 hr. Other hormones do not stimulate accumulation of un-
phosphorylated bes1::GFP. BES1 Accumulation Is Negatively
(E) BL-induced accumulation of unphosphorylated BES1 is reduced Regulated by BIN2
in the bri1-101 background. bin2 was identified as a BR-insensitive dwarf mutant
and the dominance of the mutation suggests that BIN2
encodes a negative regulator in the BR pathway (Li et al.,
auxin, a plant hormone also involved in cell elongation, 2001). Recent identification of BIN2 as a GSK-3 makes it
did not cause BES1 nuclear accumulation (Figure 3D). a good candidate for a kinase that negatively regulates
Transgenic lines with similar phenotypes to the original BES1 (Li and Nam, 2002). To test the genetic relationship
bes1-D mutant were used to observe mutant bes1::GFP between BES1 and BIN2, we crossed homozygous
localization. In contrast to wild-type BES1::GFP, mutant bes1-D to bin2-D and found that the F1 progeny (bes1-
bes1::GFP protein was found in the nucleus at high lev- D/BES1; bin2-D/BIN2) displayed bes1-D phenotypes
els (generally more than 10 times greater than wild- (Figure 5A), indicating that bes1-D is epistatic to bin2-D.
type BES1) in most cells, including cells in dark-grown To test whether BIN2 and BES1 interacted directly, we
hypocotyls (Figure 3B, left panel). Mutant bes1::GFP examined their possible in vitro interactions in the yeast
accumulated at high levels in the nucleus of light-grown two-hybrid system and by a GST pull-down assay (Fig-
leaf mesophyll cells, tissues in which wild-type BES1 ure 5). Strong reporter gene activation was detected
could not be detected (data not shown). Treatment of when BIN2 and BES1 were coexpressed in yeast in two-
hypocotyls with 1 m BL for 24 hr did not apparently hybrid vectors, demonstrating a specific interaction be-
affect the localization or degree of fluorescence of mu- tween BIN2 and BES1 proteins (Figure 5B). To confirm
tant bes1::GFP (Figure 3B, right panel). this interaction, both wild-type and mutant BES1 pro-
To confirm the results from the fluorescence micro- teins were labeled with 35S-labeled methionine using an
scope, transgenic seedlings were treated with BL and in vitro transcription/translation system and were used
used to prepare total protein for Western analysis. As in pull-down assays with BRI1 and BIN2. Neither GST
shown in Figure 4A, BES1::GFP protein was present in nor GST-BRI1 kinase interacted with BES1 or mutant
two different forms in plants, manifested as a fast and bes1; however, a BIN2-GST fusion pulled down signifi-
a slow migrating band on SDS-PAGE. Treatment of im- cant amounts of BES1 or bes1 (Figure 5C). These results
munoprecipitated protein with calf alkaline phosphatase indicate that BIN2 interacts in vitro with both wild-type
and mutant BES1 proteins.(CIP) eliminated the slowly migrating band (Figure 4B),
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in the bin2-D/BIN2 background. In addition, the total
amount of BES1 protein was reduced in the bin2-D/BIN2
background. This result, combined with other genetic
and biochemical evidence, strongly supports that BIN2
phosphorylates BES1 in vivo, thereby keeping its levels
low in the absence of hormone.
Discussion
Despite extensive genetic screens, only two loci, BRI1
and BIN2, have been identified as BR-insensitive mu-
tants with BR-deficient phenotypes (Clouse et al., 1996;
Kauschmann et al., 1996; Li and Chory, 1997; Li et al.,
2001). In this paper, we describe a positive regulator,
BES1, that acts downstream of BRI1 and BIN2. We show
that the regulation of BES1 protein levels plays a central
role in BR signal transduction. BL treatment increases
both BES1 levels and its nuclear accumulation. In con-
trast, BES1 protein levels are negatively regulated by
BIN2 kinase. We found that mutant bes1 protein is stabi-
lized and accumulates at high levels in bes1-D. The
accumulation of bes1 protein in the mutant to levels
even higher than wild-type BES1 after BL induction pro-
vides an explanation for why bes1-D suppresses both
bri1 and bin2 dwarf phenotypes and exhibits constitu-
tive BR-response phenotypes.
Although bes1-D is a gain-of-function mutation, sev-
Figure 5. Negative Regulation of BES1 by BIN2 eral results suggest that BES1 is specific for the BR
(A) bes1-D suppresses bin2 dwarf phenotypes. Both homozygous pathway. First, consistent with the increased accumula-
(lower left) and heterozygous (lower right) bin2 mutants display a tion of mutant bes1 protein, BR-induced gene expression
dwarf phenotype that is completely suppressed by bes1-D (top).
was upregulated (Table 1), suggesting that bes1-D is a(B) BIN2 and BES1 interact in a yeast two-hybrid assay.
gain-of-function mutation in the BR response pathway.(C) A GST pull-down experiment shows direct interactions between
BIN2 and BES1 or bes1. Agarose beads containing GST-BIN2, but In addition, BL, but not auxin, induces BES1 nuclear
neither those containing GST nor GST-BRI1 kinase, pull down signif- accumulation (Figure 3). Moreover, the BL-induced ac-
icant amounts of BES1 or mutant bes1. cumulation of unphosphorylated BES1 protein is depen-
(D) BIN2 phosphorylates both MBP-BES1 and MBP-bes1 but not dent on BRI1 (Figure 4E), a critical component of the
MBP as revealed by an in vitro kinase assay. BRI1 kinase does not
BR receptor complex. Finally, the BL-induced BES1 ac-phosphorylate BES1 or mutant bes1. Arrows indicate autophos-
cumulation is BL-specific, since other plant hormonesphorylation of BIN2 and BRI1 kinases.
(E) BIN2 negatively regulates BES1 in vivo. In wild-type background such as auxin, cytokinin, abscisic acid, and gibberellin
(35S::BES1-GFP transgenic plants, left 5 lanes), unphosphorylated do not cause accumulation of BES1 (Figures 4C and 4D).
BES1-GFP accumulates in the presence of BL (similar to Figure 4C). BES1 apparently transduces the BR signal to the nu-
In the bin2 background (F1 plants of a cross between bin2 and a cleus as the protein begins to accumulate in the nucleus
35S::BES1-GFP transgenic line, right 5 lanes), both BES1 protein
as early as 30 min after BL treatments (Figure 3C). Thislevel and the BL-induced accumulation of unphosphorylated BES1
BL-induced nuclear accumulation is most likely due toare reduced. Two minor background bands above BES1 indicate
equal loading of the samples. increased BES1 protein levels in the presence of BL
as Western blot analysis indicated that BL treatment
induces the accumulation of unphosphorylated protein
within 30 min as well (Figure 4C). Since BL treatmentTo test if BIN2 phosphorylates BES1 or mutant bes1
in vitro, the proteins were expressed in E. coli, purified does not change BES1 mRNA levels (data not shown),
the hormone treatment appears to stabilize BES1 pro-with GST or MBP tags, respectively, and used in an in
vitro phosphorylation assay. BIN2 efficiently phosphory- tein. Because BIN2 interacts with BES1 and decreases
BES1 protein levels (Figure 5; see below) and BIN2 islated BES1 or mutant bes1 to a greater extent than BIN2
autophosphorylation, consistent with 22 putative BIN2 apparently localized in the cytoplasm (J.L., unpublished
data), the regulation of BES1 stability likely takes place insites in BES1 (Figure 5D, lanes 1–3). Moreover, the phos-
phorylation of BES1 and bes1 by BIN2 was specific since the cytoplasm. In the absence of BRs, newly synthesized
cytoplasmic BES1 does not accumulate due to the ac-the BRI1 kinase did not phosphorylate these proteins
(Figure 5D, lanes 4–6). tion of BIN2. In the presence of BRs, BES1 is stabilized,
allowing it to accumulate and translocate to the nucleus.To confirm that BIN2 phosphorylated BES1 in vivo,
we crossed a BES1::GFP transgenic line to bin2-D and BES1 accumulation in the nucleus appears to activate
BR target gene expression as indicated by the upregula-assayed BL-induced BES1 dephosphorylation (Figure
5E). While the accumulation of unphosphorylated BES1 tion of BL-induced genes in the bes1-D mutant (Table
1). A time course of BR-regulated gene expression cor-was clearly induced by BL in wild-type plants (Figure
5E), such accumulation of BES1 was greatly reduced relates well with BES1 nuclear accumulation. For exam-
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ple, the TCH4 gene was induced by BL in 30 min, with
a maximum induction at 2 hr, and this BL-induced TCH4
expression occurs at the level of transcription (Xu et al.,
1995). Similarly, the BRU1 gene was induced by BL
within 2 hr after treatment (Zurek and Clouse, 1994).
Although it has no recognizable DNA binding motifs,
BES1 may interact with other transcription factors to
activate BL-target gene expression. While many BL-
induced genes are upregulated in bes1-D (Group 1
genes; Table 1), some other BL-regulated genes show
normal basal levels of expression and are hyperrespon-
sive to BL treatment (Group 2; Table 1). These different
classes of BL-induced genes could result from different
requirements of BES1 for BR-induced gene expression.
For instance, BES1 may be sufficient to activate the
expression of Group1 genes, but may require other BR-
regulated factor(s) to activate the expression of Group
2 genes. It is worth noting that seven BR-induced genes
encode cell wall modifying enzymes implicated in cell
Figure 6. A Model for BR Signal Transductionelongation (Table 1) and the upregulation of these genes
could explain the constitutive cell elongation pheno- BL binding to the BRI1 receptor complex triggers BRI1 autophos-
phorylation and other uncharacterized signaling event(s). This sig-types of bes1-D.
naling inhibits the GSK-3, BIN2, that otherwise phosphorylates andWe would also like to point out that, in general, BL
destabilizes BZR1 and BES1. Stabilized BZR1 and BES1 translocatetreatments led to small changes in gene expression (on
to the nucleus and activate target gene expression, presumably with
the order of 2-to 4-fold; Table 1). One explanation for the other factor(s). In the light, BZR1 activates a negative feedback
small induction of BL-induced gene expression could be pathway that inhibits the BR-biosynthetic genes such as CPD and
that the BR biosynthetic pathway is tightly controlled DWARF4 and leads to reduced cell elongation. The BR-induced
genes work together with the V-ATPase pathway to promote cellby a feedback inhibition mechanism. Expression of the
elongation and other BR responses. The proposed BR signalingBL biosynthetic gene CPD is inhibited by addition of
pathway is analogous to the Wnt pathway that is involved in cellexogenous BRs, and such feedback inhibition requires
fate control and proliferation (adapted from Polakis, 2000).functional BRI1 (Mathur et al., 1998), suggesting that
a BRI1-mediated signaling event is required for CPD
feedback inhibition. In addition, there is evidence that genes are expressed in light-grown plants (Figure 2 and
another BL biosynthetic gene, DWF4, is also under the data not shown), suggesting that the different pheno-
control of negative feedback inhibition through the BR types are not caused by differential gene expression.
signaling pathway (Noguchi et al., 2000).
Light could modulate either the levels or activities of
The inability to obtain additional BR pathway dwarf
BES1 and BZR1 differently. Alternatively, the functions
mutants through genetic screens implies that a bes1
of BES1 and BZR1 in the activation of target genes might
loss-of-function mutant may not have a BR-deficient
be differentially modified by a component in the light-dwarf phenotype. The close homology of BES1 with
signaling pathway. There is evidence for regulation ofBZR1 and several other related genes suggest that these
BR levels by the phototransduction pathways (Kang etgene products may act partially redundantly to trans-
al., 2001; Neff et al., 1999). BES1 and BZR1 provideduce the BR signal. Alternatively, bes1 loss-of-function
potential targets for crosstalk between the light and BRmutants may be lethal if BES1 has other critical cellular
signaling pathways.functions. Identification of null mutants of BES1, BZR1,
The accumulation of BES1 in its unphosphorylatedand related genes should distinguish between these two
form in response to BL suggests that BES1 is regulatedpossibilities. We are still searching for such mutants.
by a negatively acting kinase. Several lines of evidenceAlthough bes1-D and bzr1-D seedlings are each resis-
support the conclusion that BIN2 is the kinase (Figuretant to BRZ in the dark, they appear to have distinct
5). First, the complete suppression of bin2 dwarf pheno-functions in the light. When grown in the light, bes1-D
types by bes1-D provides strong genetic evidence thatplants display constitutive BR response phenotypes in-
BES1 acts downstream of BIN2. Second, BIN2 and BES1cluding long and bending leaf petioles, curly leaves,
interact directly in both yeast two-hybrid assays andupregulation of BR-induced genes, and resistance to
GST pull-down experiments. Third, BIN2, but not BRI1BRZ, whereas bzr1-D plants exhibit semi-dwarf pheno-
kinase, efficiently phosphorylates BES1 in vitro. Last, intypes and are hypersensitive to BRZ (Figure 1; Table 1;
the bin2 mutant background in which BIN2 kinase activ-Wang et al., 2002). The bzr1-D mutation seems to acti-
ity is increased, BL-induced accumulation of unphos-vate a BR feedback inhibition pathway that results in
phorylated BES1 protein is greatly reduced. These re-reduced BR content and semi-dwarf phenotypes (Wang
sults suggest that BIN2 phosphorylates BES1 and suchet al., 2002). In contrast, an identical amino acid change
phosphorylation most likely destabilizes BES1, decreas-in BES1 causes constitutive BR response phenotypes
ing its protein levels in vivo. The fact that stabilizedthat are not subject to BR feedback inhibition.
mutant bes1 protein is still phosphorylated by BIN2 inThe difference in phenotypes between bzr1-D and
vitro and in vivo (Figures 4 and 5) suggests that BES1bes1-D suggest that these two genes or gene products
are differentially regulated by light. Both BES1 and BZR1 phosphorylation is necessary but not sufficient for BES1
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protein turnover. Other functions (i.e., those affected by tein- coupled receptor) and coreceptor LPR (low-density
the bes1 mutation) may regulate BES1 protein stability lipoprotein receptor-related protein; Huelsken and
as well. The bes1 mutation lies within a putative PEST Birchmeier, 2001). It will be interesting to determine if
sequence that is involved in proteolysis (Figure 2; Rech- other components in the BR pathway share homology
steiner and Rogers, 1996). The mutation could disrupt to Wnt signaling components or if it is simply the logic
BES1’s interaction with the protein degradation machin- of the signaling pathway that is conserved.
ery, thereby stabilizing the mutant protein regardless of Our results thus provide a crucial link in the signal
its phosphorylation status. It is possible that both the transduction pathway of brassinosteroids to changes in
residue mutated in bes1-D and BES1 phosphorylation is gene expression. However, there are still significant
required to recruit a BES1 protein degradation complex. gaps in this proposed BR signaling pathway. The mech-
Based on our results, we propose a model for BR anisms by which BES1 is regulated and by which BES1
signal transduction (Figure 6). In the absence of BRs, activates target genes are largely unknown. In addition,
the negative regulator BIN2 phosphorylates BES1, and it is not known how BL-induced BRI1 autophosphoryla-
this phosphorylation likely leads to rapid turnover of tion regulates BIN2 activity. The negative regulation of
BES1, preventing its accumulation in the nucleus. In the BES1 by BIN2 in the absence of the hormone implies
presence of BL, the hormone binds a BRI1-containing that BR signaling through BRI1 inhibits BIN2 function.
complex and induces BRI1 autophosphorylation and Since no direct interaction or phosphorylation was found
other signaling events. Initiation of these events inhibits between BRI1 and BIN2 (Li and Nam, 2002), other factors
BIN2 kinase activity by an unknown mechanism and likely act between these two BR signaling components.
prevents it from phosphorylating BES1. This, in turn, Genetic and biochemical approaches should help to
results in an increased level of unphosphorylated BES1 identify other signaling components in the pathway and
and its nuclear accumulation. The nuclear localized will aid in determining the mechanism by which plant
BES1 then activates the expression of BR-induced steroids signal from the cell surface to the nucleus.
genes such as those encoding cell-wall modifying en-
zymes required for cell elongation, by interacting with Experimental Procedures
other cofactors. Unlike BES1, BZR1 seems to play a
Plant Materials and Growth Conditionsmajor role in the activation of the BR negative feedback
Arabidopsis thaliana ecotypes Enkheim-2 (En2) or Columbia (Col)pathway that inhibits BR-induced cell elongation in a
were the wild-type. Seeds were germinated either on 1⁄2 MS mediumlight-dependent manner (Wang et al., 2002). In addition
(Gibco BRL) plus 1% sucrose or directly in soil. Plants were grown
to these two subpathways that regulate gene expres- under fluorescent light (16 hr light/8 hr dark cycles).
sion, BRI1 also appears to signal directly to the
V-ATPase, the action of which may increase the turgor Isolation of bri1-119 Suppressor Mutants
pressure of cells (Schumacher et al., 1999). The Three grams of bri1-119 seeds (En2 background) were sterilized,
hydrated, and treated with 0.2% EMS (Sigma) for 14 hr. After exten-V-ATPase subpathway appears to act independently of
sive washes with water, the seeds were vernalized at 4C for 4 daysthe other two because mutations in det3 affect cell
and sown in soil. About 40,000 M1 plants were self pollinated andexpansion, in the absence of alterations of gene expres-
M2 seeds were collected in 38 pools (1000 M1/pool). About 5000sion (Cabrera y Poch et al., 1993). We propose that
M2 seeds (100 mg) from each pool were germinated in 1⁄2 MS mediumthe coordinated actions of these pathways lead to BR- and grown in the light for 4 weeks. The plants that showed suppres-
induced cell elongation and other BR responses. sion of bri1 dwarf phenotypes were transferred to soil. The candidate
Surprisingly, this proposed BR signaling pathway suppressors were genotyped with a bri1-119 CAPS marker. The
confirmed suppressors were crossed to either bri1-119 to determineshares some similarity to the Wnt signaling pathway
the dominant or recessive nature of the mutation or to wild-type(Cadigan and Nusse, 1997; Miller et al., 1999; Polakis,
En2 to obtain the mutant in a wild-type BRI1 background.2000). In this model, BES1 is analogous to -catenin, a
Wnt effector protein whose protein level and nuclear
Microarray Analysisaccumulation is regulated by GSK-3 in complex with
Ten-day-old seedlings of wild-type (Col), bes1-D (a recapitulation
the scaffolding proteins axin and APC (Huelsken and transgenic line showing similar phenotypes to the bes1-D mutant,
Birchmeier, 2001; Woodgett, 2001). In the absence of see below), and bri1-116 grown on 1⁄2 MS were treated or mock
the Wnt signal, GSK-3 phosphorylates -catenin and treated with 1 M BL for 2.5 hr and used to prepare RNA using
the Plant RNeasy Kit (QIAGEN). Probe preparation, hybridizationtargets it for degradation (Hart et al., 1999). Wnt signaling
to Affymetrix Arabidopsis genomic arrays, washing, staining, andinhibits GSK-3 activity and prevents it from phosphory-
scanning were carried out according to the manufacturer’s sugges-lating -catenin. The unphosphorylated -catenin accu-
tions (Affymetrix, Inc). The data were analyzed with GeneSpringmulates and translocates to the nucleus where it inter-
Program (Silicon Genetics).
acts with the TCF family of transcription factors to
activate Wnt target gene expression (Sharpe et al., BES1 Constructs and Transgenic Plants
2001). In addition to the sequence homology between BES1 cDNA was amplified by RT-PCR using first strand cDNA gener-
BIN2 and GSK-3 (Li and Nam, 2002), their corresponding ated from wild-type Col RNA using Pfu DNA polymerase (Stra-
substrates BES1 and-catenin are both negatively regu- tagene). Mutant bes1 cDNA was obtained by PCR with primers
containing the point mutation. BES1 and bes1 cDNAs were clonedlated by the kinases, are both stabilized upon ligand
into the binary vector CHF3-GFP, a derivative of pPZP212 (Hajdukie-treatment, and accumulate in the nucleus to activate
wicz et al., 1994) that contains a CaMV 35S promoter, a GFP codingtarget gene expression. It is important to emphasize,
region (Friedrichsen et al., 2000), and the rbcS terminator (C. Fank-
however, that BES1 does not share any protein se- hauser, Y.Y., and J.C., unpublished data). A BES1 genomic fragment
quence identity to -catenin. In addition, BRI1 is an LRR containing 2 kb of promoter, two exons, and the intron were ampli-
receptor serine/threonine kinase that is different from fied from BAC F18O14 DNA (ABRC, Ohio) by PCR and cloned into
pPZP211 together with a GFP-rbcS terminator fragment from CHF3-the Wnt receptor frizzled (seven-transmembrane G pro-
Cell
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